Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 102841-42-9 Chemical Structure| 102841-42-9

Structure of Mulberroside A
CAS No.: 102841-42-9

Chemical Structure| 102841-42-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Mulberroside A, the major active anti-tyrosinase compound in the root bark extract of Morus alba L.

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Mulberroside A

CAS No. :102841-42-9
Formula : C26H32O14
M.W : 568.52
SMILES Code : O[C@H]([C@@H](O)[C@@H]1O)[C@@H](O[C@@H]1CO)OC2=CC(/C=C/C(C=CC(O[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3CO)=C4)=C4O)=CC(O)=C2
English Name :(2S,3R,4S,5S,6R)-2-(3-Hydroxy-4-((E)-3-hydroxy-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)styryl)phenoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
MDL No. :MFCD16294844
InChI Key :HPSWAEGGWLOOKT-VUNDNAJOSA-N
Pubchem ID :6443484

Safety of Mulberroside A

Related Pathways of Mulberroside A

MAPK
pyroptosis
TLR

Isoform Comparison

Biological Activity

Target
  • JNK

In Vitro:

Cell Line
Concentration Treated Time Description References
Murine peritoneal macrophages 20 or 40 μM 24 hours To evaluate the effect of Mulberroside A on macrophage activation. Results showed that MulA treatment significantly reduced the mRNA levels of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β in LPS-stimulated macrophages. Food Sci Nutr. 2023 Mar 31;11(6):3433-3441
Human hepatic stellate cells LX-2 20 or 40 μM 24 hours To evaluate the effect of Mulberroside A on the proliferation and activation of LX-2 cells. Results showed that MulA treatment had no significant impact on LX-2 cell proliferation or the mRNA levels of collagen I and ACTA2. Food Sci Nutr. 2023 Mar 31;11(6):3433-3441
Morus alba root culture 200 µM MJ and 2 mg/mL YS 24 hours Investigated the effect of elicitors on stilbene accumulation, finding the highest accumulation of Mulberroside A after 24 hours of co-treatment with MJ and YS. Bioprocess Biosyst Eng. 2021 Apr;44(4):653-660
Morus alba root culture 19.0 mg/g 10 days Studied the effect of precursor feeding on stilbene accumulation, finding the highest accumulation of Mulberroside A after 10 days of TYR feeding. Bioprocess Biosyst Eng. 2021 Apr;44(4):653-660
Morus alba root culture 3 g/flask 4 weeks Investigated the effect of root density on growth and stilbene accumulation, finding the highest accumulation of Mulberroside A at 3 g/flask initial inoculum density. Bioprocess Biosyst Eng. 2021 Apr;44(4):653-660

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/c mice CCl4-induced liver fibrosis model Intragastric administration 20 or 40 mg/g Three times a week for 4 weeks To evaluate the effect of Mulberroside A on CCl4-induced liver fibrosis. Results showed that MulA treatment significantly alleviated liver injury and fibrosis, reduced collagen deposition, and suppressed pro-inflammatory cytokine expression. Food Sci Nutr. 2023 Mar 31;11(6):3433-3441
Rats Oral 39.5 μg/kg Single dose Mulberroside A was not detected in rat plasma after oral administration of Naoxintong capsule Evid Based Complement Alternat Med. 2017;2017:9057238

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.79mL

1.76mL

0.88mL

17.59mL

3.52mL

1.76mL

References

 

Historical Records

Categories